California Public Employees Retirement System’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$69M Buy
211,581
+10,100
+5% +$3.29M 0.04% 307
2025
Q1
$54.4M Sell
201,481
-2,651
-1% -$716K 0.04% 359
2024
Q4
$48M Sell
204,132
-7,649
-4% -$1.8M 0.03% 396
2024
Q3
$58.2M Sell
211,781
-3,786
-2% -$1.04M 0.04% 365
2024
Q2
$52.4M Buy
215,567
+1,237
+0.6% +$301K 0.04% 372
2024
Q1
$32M Buy
214,330
+35,000
+20% +$5.23M 0.02% 487
2023
Q4
$34.3M Sell
179,330
-48,500
-21% -$9.28M 0.03% 460
2023
Q3
$40.3M Buy
227,830
+1,551
+0.7% +$275K 0.03% 408
2023
Q2
$43M Sell
226,279
-10,834
-5% -$2.06M 0.04% 398
2023
Q1
$47.5M Sell
237,113
-33,770
-12% -$6.76M 0.04% 378
2022
Q4
$64.4M Buy
270,883
+1,123
+0.4% +$267K 0.05% 330
2022
Q3
$54M Buy
269,760
+33,205
+14% +$6.65M 0.05% 347
2022
Q2
$34.5M Sell
236,555
-9,048
-4% -$1.32M 0.03% 410
2022
Q1
$40.1M Sell
245,603
-64,072
-21% -$10.5M 0.03% 429
2021
Q4
$52.5M Sell
309,675
-9,284
-3% -$1.57M 0.04% 410
2021
Q3
$60.2M Buy
318,959
+1,267
+0.4% +$239K 0.05% 379
2021
Q2
$53.9M Sell
317,692
-2,355
-0.7% -$399K 0.04% 404
2021
Q1
$45.2M Sell
320,047
-13,693
-4% -$1.93M 0.03% 443
2020
Q4
$43.4M Buy
333,740
+69,389
+26% +$9.02M 0.03% 434
2020
Q3
$38.5M Buy
264,351
+8,583
+3% +$1.25M 0.03% 415
2020
Q2
$37.9M Buy
255,768
+34,968
+16% +$5.18M 0.04% 401
2020
Q1
$24M Sell
220,800
-3,500
-2% -$381K 0.03% 439
2019
Q4
$25.8M Buy
224,300
+46,700
+26% +$5.38M 0.02% 537
2019
Q3
$14.3M Buy
177,600
+56,200
+46% +$4.52M 0.01% 705
2019
Q2
$8.81M Sell
121,400
-56,386
-32% -$4.09M 0.01% 804
2019
Q1
$16.6M Sell
177,786
-7,173
-4% -$670K 0.02% 595
2018
Q4
$13.5M Buy
184,959
+2,424
+1% +$177K 0.02% 645
2018
Q3
$16M Sell
182,535
-25,979
-12% -$2.27M 0.02% 678
2018
Q2
$20.5M Sell
208,514
-10,085
-5% -$993K 0.03% 581
2018
Q1
$26M Buy
218,599
+22,561
+12% +$2.69M 0.04% 481
2017
Q4
$24.9M Buy
196,038
+62,832
+47% +$7.98M 0.03% 521
2017
Q3
$15.7M Buy
133,206
+6,506
+5% +$764K 0.02% 651
2017
Q2
$10.1M Buy
126,700
+15,900
+14% +$1.27M 0.02% 834
2017
Q1
$5.68M Sell
110,800
-4,800
-4% -$246K 0.01% 1190
2016
Q4
$4.33M Hold
115,600
0.01% 1380
2016
Q3
$7.84M Sell
115,600
-8,000
-6% -$542K 0.01% 975
2016
Q2
$6.86M Sell
123,600
-3,900
-3% -$216K 0.01% 1068
2016
Q1
$8M Sell
127,500
-19,000
-13% -$1.19M 0.01% 961
2015
Q4
$13.8M Hold
146,500
0.02% 697
2015
Q3
$11.8M Buy
146,500
+500
+0.3% +$40.2K 0.02% 751
2015
Q2
$17.5M Buy
146,000
+47,048
+48% +$5.64M 0.03% 639
2015
Q1
$9.45M Hold
98,952
0.01% 976
2014
Q4
$9.45M Buy
98,952
+13,576
+16% +$1.3M 0.01% 976
2014
Q3
$6.67M Sell
85,376
-39,740
-32% -$3.1M 0.01% 1187
2014
Q2
$7.9M Buy
125,116
+5,205
+4% +$329K 0.01% 1134
2014
Q1
$7.49M Buy
119,911
+32,531
+37% +$2.03M 0.01% 1131
2013
Q4
$5.85M Buy
87,380
+718
+0.8% +$48K 0.01% 1302
2013
Q3
$5.55M Buy
86,662
+20,200
+30% +$1.29M 0.01% 1183
2013
Q2
$2.06M Buy
+66,462
New +$2.06M ﹤0.01% 1738